methaqualone
Sign in to saveMethaqualone is a sedative-hypnotic medication that was widely prescribed during the mid-20th century. It was marketed under various brand names, including Quaalude ( ) and Sopor, typically containing 300 mg of methaqualone per tablet. A combination drug known as Mandrax was sold primarily in Europe, containing 250 mg of methaqualone and 20 mg of diphenhydramine in a single tablet.
Key facts
- Drug.Watchedfields
- changed
- Drug.pregnancy_US
- D
- Drug.verifiedrevid
- 418472840
- Drug.IUPAC_name
- 2-Methyl-3-o-tolyl-4(3H)-quinazolinone;3,4-Dihydro-2-methyl-4-oxo-3-o-tolylquinazoline;2-Methyl-3-(2-methylphenyl)-4-(3H)-quinazolinone
- Drug.image
- Methaqualone2.svg
- Drug.image_class
- skin-invert-image
- Drug.width
- 175
- Drug.tradename
- Quaalude, Sopor, Mandrax
- Drug.legal_AU
- S9
- Drug.legal_BR
- F2
- Drug.legal_CA
- Schedule III
- Drug.legal_NZ
- Class B -illegal to possess
- Drug.legal_UK
- Class B
- Drug.legal_US
- Schedule I
- Drug.legal_DE
- Anlage II
- Drug.legal_UN
- P II
- Drug.CAS_number
- 72-44-6
- Drug.ATC_prefix
- N05
via Wikipedia infobox
Article
16 sectionsContents
- Medical use
- Overdose
- Pharmacology
- Pharmacodynamics
- Pharmacokinetics
- History
- Society and culture
- Brand names
- Regulation
- Recreational
- Chemical weapon – Project Coast
- Sexual assault
- Popular culture
- Further reading
- References
- External links
Methaqualone is a sedative-hypnotic medication that was widely prescribed during the mid-20th century. It was marketed under various brand names, including Quaalude ( ) and Sopor, typically containing 300 mg of methaqualone per tablet. A combination drug known as Mandrax was sold primarily in Europe, containing 250 mg of methaqualone and 20 mg of diphenhydramine in a single tablet.
Methaqualone belongs to the quinazolinone class of compounds. Its commercial production was discontinued in many countries during the mid-1980s due to widespread misuse, addiction, and associated public health concerns.